Mga Batayang Estadistika
| CIK | 1861795 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Definitive Healthcare Corp.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive |
|
| August 7, 2025 |
Exhibit 99.1 Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2025 Second Quarter Revenue Exceeded Guidance Framingham, MA (August 7, 2025) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended June 30, 2025. Second Quarter |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 001-40815 Delaware 86-3988281 (State of Incorporation) (IRS Em |
|
| July 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2025 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 001-40815 Delaware 86-3988281 (State of Incorporation) (IRS Emp |
|
| July 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2025 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 001-40815 Delaware 86-3988281 (State of Incorporation) (IRS Emp |
|
| June 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2025 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Commission File Number 001-40815 Delaware 86-3988281 (State of Incorporation) (IRS Empl |
|
| May 8, 2025 |
Exhibit 10.3 Definitive Healthcare Corp. 2021 Equity Incentive Plan Restricted Stock Unit Award Agreement (Performance-Based) This Restricted Stock Unit Award Agreement (this “Agreement”) is made by and between Definitive Healthcare Corp., a Delaware corporation (the “Company”), and [●] (the “Participant”), effective as of [●] (the “Date of Grant”). RECITALS WHEREAS, the Company has adopted the De |
|
| May 8, 2025 |
Exhibit 99.1 Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025 First Quarter Revenue Exceeded Guidance Framingham, MA (May 8, 2025) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2025. First Quarter 2025 |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 001-40815 Delaware 86-3988281 (State of Incorporation) (IRS Emplo |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive |
|
| April 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| April 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| February 27, 2025 |
Exhibit 99.1 Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024 Fourth quarter and full year 2024 revenue exceeded guidance Framingham, MA (February 27, 2025) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and |
|
| February 27, 2025 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Definitive Healthcare Corp. |
|
| February 27, 2025 |
Exhibit 10.38 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is by and between Definitive Healthcare, LLC (the “Company”), and William Moschella (“Employee” or “You”) (collectively referred to as the “Parties” or individually referred to as a “Party”). The “Effective Date” of this Agreement will be the Closing Date as defined in that certain Agreement and Plan of Merger dated as |
|
| February 27, 2025 |
Exhibit 21.1 Subsidiaries of the Registrant Entity Name Jurisdiction of Incorporation AIDH TopCo, LLC Delaware AIDH Buyer, LLC Delaware Definitive Healthcare Holdings, LLC Delaware Definitive Healthcare, LLC Massachusetts Analytical Wizards, Inc Delaware Analytical Wizards Services Private Ltd India Monocl Holding Company, LLC Delaware Monocl Company, LLC Delaware Monocl AB Sweden Healthcare Sales |
|
| February 27, 2025 |
Definitive Healthcare Corp. Insider Trading Policy. Exhibit 19.1 Insider Trading Policy I. INTRODUCTION A. Purpose The purpose of this Insider Trading Policy (this “Policy”) is to help Definitive Healthcare Corp. and its subsidiaries (the “Company”) comply with U.S. federal and state securities laws relating to insider trading, as well as similar laws in other countries where the Company does business, and to preserve the reputation and integrity o |
|
| February 27, 2025 |
Exhibit 10.39 HOLDBACK AGREEMENT This Holdback Agreement (this “Agreement”), dated as of July 17, 2023 is entered into by and between Analytical Wizards, Inc., a Delaware corporation (“Parent”), and (ii) Masheen, LLC (the “Holdback Stockholder” and, together with Parent, the “Parties” and each, individually, a “Party”). RECITALS WHEREAS, concurrently with the execution and delivery of this Agreeme |
|
| February 27, 2025 |
The Amended and Restated Definitive Healthcare Corp. 2023 Inducement Plan. Exhibit 10.29 DEFINITIVE HEALTHCARE CORP. AMENDED AND RESTATED 2023 INDUCEMENT PLAN 1. General. 1.1 Purpose. The purpose of the Definitive Healthcare Corp. 2023 Inducement Plan is to further align the interests of eligible participants with those of the Company’s stockholders by providing incentive compensation opportunities tied to the performance of the Company and its Common Stock. The Plan is |
|
| February 27, 2025 |
Exhibit 10.1 February 24, 2025 Casey Heller [**************************] [****************] [*******************] Dear Casey: We are thrilled to present you with the following letter outlining an offer to of promotion to the role of Chief Financial Officer of Definitive Healthcare, LLC, a Massachusetts limited liability company (the “Company”) and its parent company, Definitive Healthcare Corp., a |
|
| February 27, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2025 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 001-40815 Delaware 86-3988281 (State of Incorporation) (IRS |
|
| February 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40815 Definitive Heal |
|
| February 27, 2025 |
As filed with the Securities and Exchange Commission on February 27, 2025 As filed with the Securities and Exchange Commission on February 27, 2025 Registration No. |
|
| January 16, 2025 |
Exhibit 10.1 AMENDMENT NO. 2 THIS AMENDMENT NO. 2 (this “Amendment”), dated as of January 16, 2025, is entered into among Definitive Healthcare Holdings, LLC, a Delaware limited liability company (the “Borrower”), AIDH Buyer, LLC, a Delaware limited liability company (“Holdings”), the other Loan Guarantors party hereto, the Lenders party thereto and Bank of America, N.A., as administrative agent a |
|
| January 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 16, 2025 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 001-40815 Delaware 86-3988281 (State of Incorporation) (IRS |
|
| November 12, 2024 |
SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* DEFINITIVE HEALTHCARE CORP. (Name of Issuer) Common Stock (Title of Class of Securities) 24477E103 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| November 7, 2024 |
Exhibit 99.1 Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024 Third quarter revenue exceeded guidance, and the Company announced a $100 million repurchase authorization Framingham, MA (November 7, 2024) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced fi |
|
| November 7, 2024 |
Exhibit 10.1 VOTING AGREEMENT This Voting Agreement, dated as of November 7, 2024 (this “Agreement”), is entered into by and among Definitive Healthcare Corp., a Delaware corporation (the “Company”), Advent International, L.P., a Delaware limited partnership (“Advent”), and each of the other undersigned parties hereto (together with Advent, the “Advent Stockholders”). Each of the Company and the A |
|
| November 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2024 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 001-40815 Delaware 86-3988281 (State of Incorporation) (IRS |
|
| November 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Defini |
|
| October 3, 2024 |
EX-1 2 ex1.htm Exhibit 1 JOINT FILING AGREEMENT This Agreement will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on the date hereof with respect to the beneficial ownership by the undersigned of the shares of Class A Common Stock of Definitive Healthcare Corp. is being filed, and all amendments thereto will be filed, on |
|
| October 3, 2024 |
DH / Definitive Healthcare Corp. / Irenic Capital Management LP Passive Investment SC 13G 1 formsc13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Definitive Healthcare Corp. (Name of Issuer) Class A Common Stock, $0.001 par value (Title of Class of Securities) 24477E103 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropr |
|
| October 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2024 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 001-40815 Delaware 86-3988281 (State of Incorporation) (IR |
|
| August 5, 2024 |
Exhibit 99.1 Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2024 Second quarter revenue grew 5% year-over-year to $63.7 million Framingham, MA (August 5, 2024) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended June 30 |
|
| August 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive |
|
| August 5, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2024 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 001-40815 Delaware 86-3988281 (State of Incorporation) (IRS Em |
|
| July 30, 2024 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2024 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 001-40815 Delaware 86-3988281 (State of Incorporation) (IRS Emp |
|
| July 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 4, 2024 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 1-40815 Delaware 86-3988281 (State of Incorporation) (IRS Employ |
|
| June 12, 2024 |
The Amended and Restated Definitive Healthcare Corp. 2023 Inducement Plan Exhibit 99.1 DEFINITIVE HEALTHCARE CORP. AMENDED AND RESTATED 2023 INDUCEMENT PLAN 1. General. 1.1 Purpose. The purpose of the Definitive Healthcare Corp. 2023 Inducement Plan is to further align the interests of eligible participants with those of the Company’s stockholders by providing incentive compensation opportunities tied to the performance of the Company and its Common Stock. The Plan is i |
|
| June 12, 2024 |
As filed with the Securities and Exchange Commission on June 12, 2024 As filed with the Securities and Exchange Commission on June 12, 2024 Registration No. |
|
| June 12, 2024 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Definitive Healthcare Corp. |
|
| May 24, 2024 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2024 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 1-40815 Delaware 86-3988281 (State of Incorporation) (IRS Employ |
|
| May 24, 2024 |
Exhibit 10.2 Definitive Healthcare Corp. 2023 Inducement Plan Restricted Stock Unit Award Agreement (Performance-Based) This Restricted Stock Unit Award Agreement (this “Agreement”) is made by and between Definitive Healthcare Corp., a Delaware corporation (the “Company”), and [] (the “Participant”), effective as of [], 20[] (the “Date of Grant”). RECITALS WHEREAS, the Company has adopted the Defi |
|
| May 24, 2024 |
Exhibit 10.1 EMPLOYMENT AGREEMENT This Agreement (the “Agreement”), dated as of May 20, 2024, is made and entered into by and between, on the one hand, Definitive Healthcare, LLC, a Massachusetts limited liability company (the “Company”) and its parent company, Definitive Healthcare Corp., a Delaware corporation (“Parent”, and together with the Company, the “Company Group”), and, on the other hand |
|
| May 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive |
|
| May 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ☒ Filed by the Registrant ☐ Filed by a Party other than the Registrant Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| May 7, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2024 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 1-40815 Delaware 86-3988281 (State of Incorporation) (IRS Employe |
|
| May 7, 2024 |
Exhibit 99.1 Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2024 First quarter revenue grew 7% year-over-year to $63.5 million Framingham, MA (May 7, 2024) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 20 |
|
| April 9, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1 |
|
| April 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defi |
|
| February 29, 2024 |
Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Definitive Healthcare Corp. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Class A Commo |
|
| February 29, 2024 |
As filed with the Securities and Exchange Commission on February 28, 2024 As filed with the Securities and Exchange Commission on February 28, 2024 Registration No. |
|
| February 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2024 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 1-40815 Delaware 86-3988281 (State of Incorporation) (IRS E |
|
| February 28, 2024 |
Definitive Healthcare Corp. Incentive Compensation Recoupment Policy. Exhibit 97.1 Incentive Compensation Recoupment Policy 1. INTRODUCTION The Human Capital Management and Compensation Committee (the “HCM and Compensation Committee”) of the Board of Directors (the “Board”) of Definitive Healthcare Corp., a Delaware corporation (the “Company”), has determined that it is in the best interests of the Company and its stockholders to adopt this Incentive Compensation Re |
|
| February 28, 2024 |
Exhibit 21.1 Subsidiaries of the Registrant Entity Name Jurisdiction of Incorporation AIDH TopCo, LLC Delaware AIDH Buyer, LLC Delaware Definitive Healthcare Holdings, LLC Delaware Definitive Healthcare, LLC Massachusetts Analytical Wizards, Inc Delaware Analytical Wizards Services Private Ltd India Monocl Holding Company, LLC Delaware Monocl Company, LLC Delaware Monocl AB Sweden Healthcare Sales |
|
| February 28, 2024 |
Exhibit 99.1 Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023 Fourth quarter revenue grew 9% year-over-year to $65.9 million Full year 2023 revenue grew 13% year-over-year to $251.4 million Framingham, MA (February 28, 2024) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial |
|
| February 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40815 Definitive Heal |
|
| February 14, 2024 |
DH / Definitive Healthcare Corp. / ADVENT INTERNATIONAL CORP/MA - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Definitive Healthcare Corp. (Name of Issuer) CLASS A COMMON STOCK, $0.001 PAR VALUE PER SHARE (Title of Class of Securities) 24477E103 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
| February 13, 2024 |
DH / Definitive Healthcare Corp. / Krantz Jason Ronald - SC 13G/A Passive Investment SC 13G/A 1 jk-schedule13gaq124.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 2)* Under the Securities Exchange Act of 1934 Definitive Healthcare Corp. (Name of Issuer) Class A common stock, $0.001 par value per share (Title of Class of Securities) 24477E103 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of th |
|
| February 9, 2024 |
SC 13G/A 1 sptrm-sch13g18794.htm SPECTRUM (SEA VII MANAGEMENT, LLC) - DEFINITIVE HEALTHCARE CORP - SCH 13G/A(#2) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Definitive Healthcare Corp. (Name of Issuer) Class A Common Stock, par value $0.001 per share (Title of Class of Securities) 24477E103 (CUSIP |
|
| February 8, 2024 |
DH / Definitive Healthcare Corp. / Echo Street Capital Management LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| January 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 12, 2024 DEFINITIVE HEALTHCARE CORP. (Exact name of registrant as specified in its charter) Delaware 001-40815 86-3988281 (State or other jurisdiction of incorporation) (Commi |
|
| January 16, 2024 |
Exhibit 10.1 DEFINITIVE HEALTHCARE, LLC January 12, 2024 Robert Musslewhite [***] [***] Re: Separation Agreement and Release of Claims Dear Robert: This letter sets forth the substance of the separation agreement (the “Agreement”) which Definitive Healthcare, LLC (the “Company”) and its parent company Definitive Healthcare Corp., a Delaware corporation (“Parent”) (together with the Company, the “C |
|
| January 16, 2024 |
Exhibit 99.1 Definitive Healthcare Announces CEO Transition Jason Krantz, Founder and Executive Chairman, to Serve as Interim CEO Company Reaffirms Fourth Quarter 2023 Guidance and Issues Preliminary Guidance for 2024 Framingham, MA, January 16, 2024 – Definitive Healthcare (Nasdaq: DH) (the “Company”), an industry leader in healthcare commercial intelligence, today announced that Robert Musslewhi |
|
| January 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Definitive Healthcare Corp (Name of Issuer) Class A Common Stock, par value $.001 (Title of Class of Securities) 24477E103 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| January 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 3, 2024 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 1-40815 Delaware 86-3988281 (State of Incorporation) (IRS Emp |
|
| January 4, 2024 |
Exhibit 99.1 Team, As we embark upon this new year, I’m writing to share some critical and difficult changes that we are making to our organization to best position us for the future. As we’ve discussed in Town Halls over the last several months, we embarked on “Go for GOLD” (“Grow, Optimize, Lead Definitive Healthcare”) to assess how we are currently performing and to develop a plan to transform |
|
| November 21, 2023 |
Exhibit 10.1 THE DEFINITIVE HEALTHCARE CORP. SEVERANCE PLAN FOR EXECUTIVES The Company has adopted the Plan, effective as of the Effective Date, to provide severance pay and benefits to eligible executives of the Company in connection with Qualifying Terminations on the terms and conditions provided for herein. All capitalized terms used herein are defined in Section 1. The Plan is sponsored by th |
|
| November 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2023 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 1-40815 Delaware 86-3988281 (State of Incorporation) (IRS E |
|
| November 2, 2023 |
Exhibit 10.4 EMPLOYMENT AGREEMENT This Agreement (the “Agreement”), dated as of October 2, 2023, is made and entered into by and between Definitive Healthcare, LLC, a Massachusetts limited liability company (the “Company”), and Carrie Lazorchak (the “Executive”). Introduction The Company desires to retain the services of the Executive pursuant to the terms and conditions set forth herein and the E |
|
| November 2, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2023 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 1-40815 Delaware 86-3988281 (State of Incorporation) (IRS Em |
|
| November 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Defini |
|
| November 2, 2023 |
Exhibit 99.1 Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2023 Third quarter revenue grew 14% year-over-year to $65.3 million Framingham, MA (November 2, 2023) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended Septem |
|
| October 5, 2023 |
Exhibit 10.1 October 2, 2023 Joe Mirisola Re: Separation Agreement Dear Joe: This letter agreement (“Agreement”) sets forth the terms regarding the cessation of your employment with Definitive Healthcare, LLC (the “Company”). The effective date of cessation (i.e., your last day of employment) is the earlier of the Early Cessation Date (as defined below) or December 31, 2023 (with such effective da |
|
| October 5, 2023 |
Definitive Healthcare Names Carrie Lazorchak as Chief Revenue Officer Exhibit 99.1 Definitive Healthcare Names Carrie Lazorchak as Chief Revenue Officer Framingham, MA (October 5, 2023) – Definitive Healthcare Corp. (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that Carrie Lazorchak has been named Chief Revenue Officer, effective November 1, 2023. “I am thrilled to welcome Carrie Lazorchak to Definitive Healthcare as our new |
|
| October 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 2, 2023 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 1-40815 Delaware 86-3988281 (State of Incorporation) (IRS Emp |
|
| September 8, 2023 |
Definitive Healthcare Welcomes Scott Stephenson to Board of Directors Exhibit 99.1 Definitive Healthcare Welcomes Scott Stephenson to Board of Directors Framingham, MA (September 8, 2023) – Definitive Healthcare Corp. (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced two changes to its Board of Directors. On September 6, 2023, Scott Stephenson, the former Chief Executive Officer of Verisk Analytics, joined the Board of Directors |
|
| September 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 6, 2023 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 1-40815 Delaware 86-3988281 (State of Incorporation) (IRS E |
|
| September 6, 2023 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Definitive Healthcare Corp. |
|
| September 6, 2023 |
Exhibit 99.3 Definitive Healthcare Corp. 2023 Inducement Plan Restricted Stock Unit Award Agreement (Performance-Based) This Restricted Stock Unit Award Agreement (this “Agreement”) is made by and between Definitive Healthcare Corp., a Delaware corporation (the “Company”), and (the “Participant”), effective as of , 20 (the “Date of Grant”). RECITALS WHEREAS, the Company has adopted the Definitive |
|
| September 6, 2023 |
Exhibit 99.2 Definitive Healthcare Corp. 2023 Inducement Plan Restricted Stock Unit Award Agreement (Time-Based) This Restricted Stock Unit Award Agreement (this “Agreement”) is made by and between Definitive Healthcare Corp., a Delaware corporation (the “Company”), and (the “Participant”), effective as of , 20 (the “Date of Grant”). RECITALS WHEREAS, the Company has adopted the Definitive Healthc |
|
| September 6, 2023 |
Exhibit 99.1 THE DEFINITIVE HEALTHCARE CORP. 2023 INDUCEMENT PLAN 1. General. 1.1 Purpose. The purpose of the Definitive Healthcare Corp. 2023 Inducement Plan is to further align the interests of eligible participants with those of the Company’s stockholders by providing incentive compensation opportunities tied to the performance of the Company and its Common Stock. The Plan is intended to (a) pr |
|
| September 6, 2023 |
As filed with the Securities and Exchange Commission on September 6, 2023 As filed with the Securities and Exchange Commission on September 6, 2023 Registration No. |
|
| August 14, 2023 |
Exhibit 99.1 Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2023 Second quarter revenue grew 12% year-over-year to $61.0 million Framingham, MA (August 14, 2023) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended June |
|
| August 14, 2023 |
The Definitive Healthcare Corp. Director Compensation Plan. Exhibit 10.1 DEFINITIVE HEALTHCARE CORP. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY ADOPTED: APRIL 18, 2023 Each member of the Board of Directors (the “Board”) who is not (i) also serving as an employee of or consultant to Definitive Healthcare Corp. (the “Company”) or any of its subsidiaries or (ii) an employee of Advent International Corporation, or Spectrum Equity Management, L.P. or their respe |
|
| August 14, 2023 |
Exhibit 99.2 Definitive Healthcare Acquires Populi Acquisition broadens Definitive Healthcare’s suite of healthcare commercial intelligence solutions with new data, analytics, and visualization tools tailor-built for the provider market FRAMINGHAM, MA (August 14, 2023) – Definitive Healthcare (NASDAQ: DH), an industry leader in healthcare commercial intelligence, today announced its acquisition of |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-4 |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2023 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 1-40815 Delaware 86-3988281 (State of Incorporation) (IRS Emp |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive |
|
| August 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2023 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 1-40815 Delaware 86-3988281 (State of Incorporation) (IRS Emplo |
|
| August 1, 2023 |
Exhibit 99.2 Email to Employees Definitive Healthcare Team, I’m writing to share some very difficult news. Today, we’re reducing the size of our team by approximately 4% and saying goodbye to many talented friends and colleagues in the process. If you are among those impacted, you have already received an invitation to meet with your function leader and HR later this morning. As I’ve shared with y |
|
| August 1, 2023 |
NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: June 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the transitio |
|
| August 1, 2023 |
Exhibit 99.1 Definitive Healthcare Reports Preliminary Financial Results for Second Quarter Fiscal Year 2023, Reaffirms Full Year Guidance for Revenue and Adjusted EBITDA, and Announces Restatement of Previously Issued Financials Q2 2023 Earnings Call Moved to August 14, 2023 Framingham, MA (August 1, 2023) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an i |
|
| June 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2023 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 1-40815 Delaware 86-3988281 (State of Incorporation) (IRS Employ |
|
| June 5, 2023 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2023 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 1-40815 Delaware 86-3988281 (State of Incorporation) (IRS Employ |
|
| May 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2023 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 1-40815 Delaware 86-3988281 (State of Incorporation) (IRS Employe |
|
| May 4, 2023 |
Exhibit 99.1 Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2023 First quarter revenue grew 18% year-over-year to $59.2 million Framingham, MA (May 4, 2023) – Definitive Healthcare Corp. (“Definitive Healthcare" or the "Company") (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2 |
|
| May 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive |
|
| May 3, 2023 |
CORRESP May 3, 2023 VIA EDGAR TRANSMISSION Jenifer Gallagher John Cannarella Division of Corporation Finance Office of Energy and Transportation Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D. |
|
| April 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| April 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| February 27, 2023 |
Exhibit 10.26 November 1, 2022 David Samuels [XXXXXXX] [XXXXXXXX] Re: Separation Agreement Dear David: This letter agreement (“Agreement”) sets forth the terms regarding the cessation of your employment with Definitive Healthcare, LLC (the “Company”). The effective date of cessation (i.e., your last day of employment) is the earlier of the Early Cessation Date (as defined below) or December 31, 20 |
|
| February 27, 2023 |
EX-FILING FEES Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Definitive Healthcare Corp. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Cl |
|
| February 27, 2023 |
Power of Attorney (included on signature page to this Registration Statement). S-8 As filed with the Securities and Exchange Commission on February 27, 2023 Registration No. |
|
| February 27, 2023 |
EX-10 4 dh-ex1030.htm EX-10.30 Exhibit 10.30 February 3rd, 2015 Dear Kate: The following letter outlines an offer to join Definitive Healthcare in the capacity of Director of Product Strategy. I personally look forward to working with you to build our product, our brand and our client base in the healthcare community. Your compensation package will be comprised of the following: 1) Annual salary o |
|
| February 27, 2023 |
EX-10 2 dh-ex1017.htm EX-10.17 Exhibit 10.17 Definitive Healthcare Corp. 2021 Equity Incentive Plan Restricted Stock Unit Award Agreement (Performance-Based) This Restricted Stock Unit Award Agreement (this “Agreement”) is made by and between Definitive Healthcare Corp., a Delaware corporation (the “Company”), and [●] (the “Participant”), effective as of [●], 20[●] (the “Date of Grant”). RECITALS |
|
| February 27, 2023 |
Definitive Healthcare Corp. Change in Control Severance Plan for Executives. Exhibit 10.36 THE DEFINITIVE HEALTHCARE CORP. CHANGE IN CONTROL SEVERANCE PLAN FOR EXECUTIVES The Company has adopted the Plan, effective as of the Effective Date, to provide severance pay and benefits to eligible executives of the Company in connection with a Change in Control of the Company on the terms and conditions provided for herein. All capitalized terms used herein are defined in Section |
|
| February 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40815 Definitive Heal |
|
| February 23, 2023 |
Exhibit 10.1 February 16, 2023 Jason Krantz RE: Amendment to Executive Chairman Agreement and Employment Agreement Dear Jason: You and Definitive Healthcare, LLC, a Massachusetts limited liability company (the “Company”) and its parent company Definitive Healthcare Corp., a Delaware corporation (“Parent”) (together with the Company, the “Company Group”) are parties to that certain Executive Chairm |
|
| February 23, 2023 |
Exhibit 99.1 Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2022 Fourth quarter revenue grew 31% year-over-year to $60.6 million Full year 2022 revenue grew 34% to $222.7 million Framingham, MA (February 23, 2023) – Definitive Healthcare Corp. (“Definitive Healthcare" or the "Company") (Nasdaq: DH), an industry leader in healthcare commercial intelligence, |
|
| February 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2023 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 1-40815 Delaware 86-3988281 (State of Incorporation) (IRS E |
|
| February 23, 2023 |
Exhibit 10.2 DEFINITIVE HEALTHCARE CORP. CASH INCENTIVE PLAN Effective February 16, 2023 1. Purposes of the Plan. The Plan is intended to increase stockholder value and the success of the Company by motivating Employees to (a) perform to the best of their abilities, and (b) achieve the Company’s objectives. 2. Definitions. (a) “Actual Award” means, as to any Performance Period, the actual award (i |
|
| February 14, 2023 |
DH / Definitive Healthcare Corp - Class A / Echo Street Capital Management LLC Passive Investment SC 13G 1 d994028513g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) Definitive Healthcare Corp. (Name of Issuer) Class A Common Stock, $0.001 par value (Title of Class of Securities) 24477E103 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropria |
|
| February 14, 2023 |
SC 13G/A 1 sptrm-sch13g18698.htm SPECTRUM (SEA VII MANAGEMENT, LLC) - DEFINITIVE HEALTHCARE CORP - SCH 13G/A(#1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Definitive Healthcare Corp. (Name of Issuer) Class A Common Stock, par value $0.001 per share (Title of Class of Securities) 24477E103 (CUSIP |
|
| February 13, 2023 |
DH / Definitive Healthcare Corp - Class A / Krantz Jason Ronald - SC 13G/A Passive Investment SC 13G/A 1 d371824dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 1)* Under the Securities Exchange Act of 1934 Definitive Healthcare Corp. (Name of Issuer) Class A common stock, $0.001 par value per share (Title of Class of Securities) 24477E103 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this St |
|
| January 12, 2023 |
Exhibit 99.1 Email to Employees Definitive Healthcare team: Today I’m announcing the most difficult decision that we’ve ever had to make at Definitive Healthcare. We’re reducing the size of our team by around 6% and saying goodbye to many talented friends and colleagues in the process. If you are among those impacted, you have already received an invitation to meet with an ELT member later this mo |
|
| January 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 12, 2023 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 1-40815 Delaware 86-3988281 (State of Incorporation) (IRS Em |
|
| November 3, 2022 |
Exhibit 10.5 Execution Version AMENDMENT NO. 1 THIS AMENDMENT NO. 1 (this ?Amendment?), dated as of October 31, 2022, is entered into among Definitive Healthcare Holdings, LLC, a Delaware limited liability company (the ?Borrower?), AIDH Buyer, LLC, a Delaware limited liability company (?Holdings?), the other Loan Guarantors party hereto, the Lenders party thereto and BANK OF AMERICA, N.A., as admi |
|
| November 3, 2022 |
Definitive Healthcare Names Jon Maack as President Effective November 3, 2022 Exhibit 99.2 Definitive Healthcare Names Jon Maack as President Effective November 3, 2022 FRAMINGHAM, MA ? November 3, 2022 ? Definitive Healthcare Corp. (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced Jon Maack has joined the company as President, effective November 3, 2022. Maack will report to Definitive Healthcare CEO Robert Musslewhite and have respons |
|
| November 3, 2022 |
Exhibit 10.4 Musslewhite 2021 RSU Amendment AMENDMENT TO RESTRICTED STOCK UNIT AWARD AGREEMENTS This Amendment (the ?Amendment?) to the Restricted Stock Unit Award Agreements (as defined below) between Robert Musslewhite (?Participant?) and Definitive Healthcare Corp. (the ?Company?) is effective as of August 9, 2022. RECITALS A. On October 7, 2021, the Company granted to Participant two restricte |
|
| November 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Defini |
|
| November 3, 2022 |
Exhibit 99.1 Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2022 Third quarter revenue grew 33% year-over-year to $57.4 million Framingham, MA (November 3, 2022) ? Definitive Healthcare Corp. (?Definitive Healthcare" or the "Company") (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended Septem |
|
| November 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2022 Definitive Healthcare Corp. (Exact name of Registrant as Specified in Its Charter) Commission File Number 1-40815 Delaware 86-3988281 (State of Incorporation) (IRS Em |
|
| November 3, 2022 |
Exhibit 10.2 Definitive Healthcare Corp. 2021 Equity Incentive Plan Restricted Stock Unit Award Agreement This Restricted Stock Unit Award Agreement (this ?Agreement?) is made by and between Definitive Healthcare Corp., a Delaware corporation (the ?Company?), and [?] (the ?Participant?), effective as of [?], 2022 (the ?Date of Grant?). RECITALS WHEREAS, the Company has adopted the Definitive Healt |
|
| November 3, 2022 |
Exhibit 10.1 EMPLOYMENT AGREEMENT This Agreement (the ?Agreement?), dated as of September 22, 2022, is made and entered into by and between Definitive Healthcare, LLC, a Massachusetts limited liability company (the ?Company?), and Jonathan Maack (the ?Executive?). Introduction The Company desires to retain the services of the Executive pursuant to the terms and conditions set forth herein and the |
|
| October 7, 2022 |
Exhibit 4.4 DEFINITIVE HEALTHCARE CORP. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of , 20 Debt Securities TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions of Terms 1 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 5 Section 2.01 Designation and Terms of Securities 5 Section 2.02 Form of Securities and Trustee?s Certificate 8 Sec |
|
| October 7, 2022 |
Form of Preferred Stock Warrant Agreement and Warrant Certificate Exhibit 4.7 DEFINITIVE HEALTHCARE CORP. AND , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF , 20 DEFINITIVE HEALTHCARE CORP. FORM OF PREFERRED STOCK WARRANT AGREEMENT THIS PREFERRED STOCK WARRANT AGREEMENT (this ?Agreement?), dated as of , 20, between Definitive Healthcare Corp., a Delaware corporation (the ?Company?), and [?], a [corporation] [national banking association |
|
| October 7, 2022 |
As filed with the U.S. Securities and Exchange Commission on October 7, 2022 Table of Contents As filed with the U.S. Securities and Exchange Commission on October 7, 2022 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Delaware 86-3988281 (State or other jurisdiction of incorporati |
|
| October 7, 2022 |
Form of Debt Securities Warrant Agreement and Warrant Certificate Exhibit 4.8 DEFINITIVE HEALTHCARE CORP. AND , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF , 20 DEFINITIVE HEALTHCARE CORP. FORM OF DEBT SECURITIES WARRANT AGREEMENT THIS DEBT SECURITIES WARRANT AGREEMENT (this ?Agreement?), dated as of , 20, between Definitive Healthcare Corp., a Delaware corporation (the ?Company?), and [?], a [corporation] [national banking association |
|
| October 7, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Definitive Healthcare Corp. |
|
| October 7, 2022 |
Form of Class A Common Stock Warrant Agreement and Warrant Certificate Exhibit 4.6 DEFINITIVE HEALTHCARE CORP. AND , AS WARRANT AGENT FORM OF CLASS A COMMON STOCK WARRANT AGREEMENT DATED AS OF , 20 DEFINITIVE HEALTHCARE CORP. FORM OF CLASS A COMMON STOCK WARRANT AGREEMENT THIS CLASS A COMMON STOCK WARRANT AGREEMENT (this ?Agreement?), dated as of , 20, between Definitive Healthcare Corp., a Delaware corporation (the ?Company?), and [?], a [corporation] [national bank |
|
| October 3, 2022 |
Exhibit 99.1 Definitive Healthcare Announces Changes to Board of Directors Sastry Chilukuri joins Board of Directors and Randy Winn departs FRAMINGHAM, MA ? October 3, 2022 ? Definitive Healthcare Corp. (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced two changes to its Board of Directors. On September 30, 2022, Sastry Chilukuri, who currently serves as co-ch |
|
| October 3, 2022 |
EX-10.1 2 d383931dex101.htm EX-10.1 Exhibit 10.1 Definitive Healthcare Corp. 2021 Equity Incentive Plan Restricted Stock Unit Award Agreement Participant: [ ] Date of Grant: [ ] Vesting Start Date: [ ] RSUs Granted: [ ] This Restricted Stock Unit Award Agreement (this “Agreement”) is made by and between Definitive Healthcare Corp., a Delaware corporation (the “Company”), and Participant, effective |
|
| October 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 29, 2022 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Commission file number 1-40815 Delaware 86-3988281 (State of incorporation) (I.R. |
|
| August 4, 2022 |
Exhibit 99.1 Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2022 Second quarter revenue grew 37% year-over-year to $54.5 million Framingham, MA (August 4, 2022) ? Definitive Healthcare Corp. (?Definitive Healthcare?) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended June 30, 2022. Second Q |
|
| August 4, 2022 |
Definitive Healthcare Corp. 2021 Equity Incentive Plan Restricted Stock Unit Award Agreement This Restricted Stock Unit Award Agreement (this ?Agreement?) is made by and between Definitive Healthcare Corp., a Delaware corporation (the ?Company?), and Robert Musslewhite (the ?Participant?), effective as of May 3, 2022 (the ?Date of Grant?). RECITALS WHEREAS, the Company has adopted the Definitive H |
|
| August 4, 2022 |
Definitive Healthcare Corp. 2021 Equity Incentive Plan Restricted Stock Unit Award Agreement This Restricted Stock Unit Award Agreement (this ?Agreement?) is made by and between Definitive Healthcare Corp., a Delaware corporation (the ?Company?), and Robert Musslewhite (the ?Participant?), effective as of May 3, 2022 (the ?Date of Grant?). RECITALS WHEREAS, the Company has adopted the Definitive H |
|
| August 4, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 4, 2022 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Commission file number 1-40815 Delaware 86-3988281 (State of incorporation) (I.R.S. E |
|
| August 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive |
|
| August 4, 2022 |
Definitive Healthcare Corp. 2021 Equity Incentive Plan Restricted Stock Unit Award Agreement This Restricted Stock Unit Award Agreement (this ?Agreement?) is made by and between Definitive Healthcare Corp., a Delaware corporation (the ?Company?), and Robert Musslewhite (the ?Participant?), effective as of May 3, 2022 (the ?Date of Grant?). RECITALS WHEREAS, the Company has adopted the Definitive H |
|
| May 26, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 24, 2022 (Date of earliest event reported) DEFINITIVE HEALTHCARE CORP. (Exact name of registrant as specified in its charter) Delaware 1-40815 86-3988281 (State or other jurisdiction of incorporation) (Commission |
|
| May 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| May 5, 2022 |
Exhibit 10.2 Execution Version Executive Chairman Agreement THIS EXECUTIVE CHAIRMAN AGREEMENT (this “Agreement”), dated as of May 4, 2022, is entered into by and between, on the one hand Definitive Healthcare, LLC, a Massachusetts limited liability company (the “Company”) and its parent company Definitive Healthcare Corp., a Delaware corporation (“Parent”) (together with the Company, the “Company |
|
| May 5, 2022 |
Exhibit 10.1 Execution Version AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Amended and Restated Employment Agreement (the “Agreement”), dated as of May 4, 2022 (the “Effective Date”), is made and entered into by and between, on the one hand, Definitive Healthcare, LLC, a Massachusetts limited liability company (the “Company”) and its parent company Definitive Healthcare Corp., a Delaware corpor |
|
| May 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive |
|
| May 5, 2022 |
Exhibit 99.1 Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2022 First quarter revenue grew 36% year-over-year to $50.1 million Framingham, MA (May 5, 2022) – Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2022. First Quarte |
|
| May 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 3, 2022 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Commission file number 1-40815 Delaware 86-3988281 (State of incorporation) (I.R.S. Empl |
|
| May 5, 2022 |
Exhibit 99.2 Definitive Healthcare Names Robert Musslewhite as CEO Effective August 1, 2022 Founder & CEO Jason Krantz will become Executive Chairman FRAMINGHAM, MA – May 5, 2022 – Definitive Healthcare Corp. (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Board of Directors has appointed Robert Musslewhite as the company’s next CEO, effective Augus |
|
| April 12, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| April 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| March 15, 2022 |
Exhibit 10.12 THE DEFINITIVE HEALTHCARE CORP. 2021 EQUITY INCENTIVE PLAN 1. Purpose. The purpose of the Definitive Healthcare Corp. 2021 Equity Incentive Plan is to further align the interests of eligible participants with those of the Company?s stockholders by providing incentive compensation opportunities tied to the performance of the Company and its Common Stock. The Plan is intended to advanc |
|
| March 15, 2022 |
Exhibit 4.1 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Definitive Healthcare, a Delaware corporation, had one class of securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934 (the ?Exchange Act?), as amended: Class A common stock, par value $0.001 per share (the ?Class A common stock?). The fol |
|
| March 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40815 Definitive Heal |
|
| February 23, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 18, 2022 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Commission file number 1-40815 Delaware 86-3988281 (State of incorporation) (I.R.S |
|
| February 23, 2022 |
Exhibit 99.1 Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Year Fiscal 2021 Fourth quarter revenue grew 38% year-over-year to $46.3 million Full year 2021 revenue grew 40% to $166.2 million Framingham, MA (February 23, 2022) ? Definitive Healthcare Corp. (?Definitive Healthcare?) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced f |
|
| February 14, 2022 |
DH / Definitive Healthcare Corp - Class A / ADVENT INTERNATIONAL CORP/MA - SC 13G Passive Investment SC 13G 1 brhc10033930sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* Definitive Healthcare Corp. (Name of Issuer) CLASS A COMMON STOCK, $0.001 PAR VALUE PER SHARE (Title of Class of Securities) 24477E103 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Stat |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ???)* Definitive Healthcare Corp. (Name of Issuer) Class A Common Stock, par value $0.001 per share (Title of Class of Securities) 24477E103 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to |
|
| February 14, 2022 |
EX-99.1 2 brhc10033930ex99-1.htm EXHIBIT 99.1 CUSIP No. 24477E103 SCHEDULE 13G Page 51 of 57 Pages EXHIBIT 99.1 JOINT FILING AGREEMENT Each of the undersigned, pursuant to Rule 13d-1(k)(1) under the Act, hereby agrees and acknowledges that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of the Class A Com |
|
| February 11, 2022 |
DH / Definitive Healthcare Corp - Class A / Krantz Jason Ronald - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No.)* Under the Securities Exchange Act of 1934 Definitive Healthcare Corp. (Name of Issuer) Class A common stock, $0.001 par value per share (Title of Class of Securities) 24477E103 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to des |
|
| November 19, 2021 |
11,000,000 Shares Definitive Healthcare Corp. Class A Common Stock Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-261083 PROSPECTUS 11,000,000 Shares Definitive Healthcare Corp. Class A Common Stock We are offering 11,000,000 shares of Class A common stock of Definitive Healthcare Corp. Our Class A common stock is listed on Nasdaq Global Select Market (?Nasdaq?) under the symbol ?DH.? On November 17, 2021, the last sale price of our commo |
|
| November 16, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 10, 2021 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Commission file number 1-40815 Delaware 86-3988281 (State of incorporation) (I.R.S |
|
| November 15, 2021 |
Exhibit 10.21 STOCK AND UNIT PURCHASE AGREEMENT THIS STOCK AND UNIT PURCHASE AGREEMENT (this ?Agreement?) is entered into as of November 10, 2021 by and among Definitive Healthcare Corp., a Delaware corporation (the ?Company?), and certain persons listed on Schedule I hereto (each such securityholder a ?Seller? and collectively, the ?Sellers?). BACKGROUND A. The Company has determined to effect an |
|
| November 15, 2021 |
Form of Underwriting Agreement. Exhibit 1.1 Definitive Healthcare Corp. 11,000,000 Shares of Class A Common Stock Underwriting Agreement [?], 2021 Goldman Sachs & Co. LLC J.P. Morgan Securities LLC Morgan Stanley & Co. LLC Barclays Capital Inc. As Representatives of the several Underwriters listed in Schedule 1 hereto c/o Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 c/o J.P. Morgan Securities LLC 383 Madison |
|
| November 15, 2021 |
DEFINITIVE HEALTHCARE CORP. 550 Cochituate Rd Framingham, MA 01701 November 15, 2021 DEFINITIVE HEALTHCARE CORP. 550 Cochituate Rd Framingham, MA 01701 November 15, 2021 VIA EDGAR AND EMAIL Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street, NE Washington, D.C. 20549-3561 Attn: Matthew Crispino Re: Definitive Healthcare Corp. Registration Statement on Form S-1 Filed on November 15, 2021 Ladies and Gentlemen: We refer to the registr |
|
| November 15, 2021 |
[Remainder of page intentionally left blank] VIA EDGAR November 15, 2021 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Definitive Healthcare Corp. (the ?Company?) Registration Statement on Form S-1 (File No. 333-261083) Ladies and Gentlemen: As representatives of the several underwriters of the Company?s proposed public offering of its Class A common stock, we hereby join the Company?s request that the effe |
|
| November 15, 2021 |
Table of Contents As filed with the Securities and Exchange Commission on November 15, 2021 Registration No. |
|
| November 8, 2021 |
Exhibit 10.13 NOMINATING AGREEMENT This Nominating Agreement (this ?Agreement?), dated as of September 17, 2021, by and among Definitive Healthcare Corp., a Delaware corporation (the ?Company?), and Jason Krantz. WHEREAS, the Company has determined that it is in its best interests to effect an initial public offering (?IPO?) of shares of its Class A common stock, par value $0.001 per share (togeth |
|
| November 8, 2021 |
Exhibit 3.3 SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT of AIDH TOPCO, LLC Dated as of September 14, 2021 WEIL:\98074461\9\40590.0003 Article 1 DEFINITIONS AND USAGE 5 Section 1.01. Definitions. 5 Section 1.02. Other Definitional and Interpretative Provisions 15 Article 2 THE COMPANY 16 Section 2.01. Formation 16 Section 2.02. Name 16 Section 2.03. Term 17 Section 2.04. Registe |
|
| November 8, 2021 |
Exhibit 10.17 INDEPENDENT CONTRACTOR SERVICES AGREEMENT THIS INDEPENDENT CONTRACTOR SERVICES AGREEMENT (the ?Agreement?) is made as of October 1, 2021 (the ?Effective Date?), by and between Definitive Healthcare LLC (?Company?), and Kevin P. Shone, AN INDIVIDUAL (?Contractor?). The parties hereby agree as follows: 1. Engagement of Contractor. Subject to the terms and conditions of this Agreement, |
|
| November 8, 2021 |
Exhibit 10.8 REORGANIZATION AGREEMENT This REORGANIZATION AGREEMENT (this ?Agreement?), dated as of September 14, 2021, is entered into by and among (a) AIDH TopCo, LLC, a Delaware limited liability company (the ?Company?); (b) Definitive Healthcare Corp., a Delaware corporation (?Pubco?) and (c) AIDH Holdings, Inc., a Delaware corporation (?Advent Blocker?); SE VII DHC AIV, L.P., a Delaware limit |
|
| November 8, 2021 |
Weil Draft 9/13/2021 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF DEFINITIVE HEALTHCARE CORP. (a Delaware corporation) Effective September 14, 2021 ARTICLE I STOCKHOLDERS Section 1.01. Annual Meetings. The annual meeting of the stockholders of Definitive Healthcare Corp. (the ?Corporation?) for the election of directors and for the transaction of such other business as properly may come before such |
|
| November 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Defini |
|
| November 8, 2021 |
Exhibit 10.14 AIDH TOPCO, LLC CONFIDENTIAL September 17, 2021 AIDH TopCo, LLC 550 Cochituate Rd Framingham, MA 01701 Attention: David A. Samuels Expense Reimbursement Letter ? Transactions Ladies and Gentlemen: We are writing to acknowledge the agreement of certain parties listed on the signature pages hereto (?you? or ?your?) to work with AIDH TopCo, LLC (the ?Company?, ?our?, ?us?, or ?we?) and |
|
| November 8, 2021 |
Exhibit 10.11 NOMINATING AGREEMENT This Nominating Agreement (this ?Agreement?), dated as of September 17, 2021, by and among Definitive Healthcare Corp., a Delaware corporation (the ?Company?), and Advent International GPE IX Limited Partnership (?Advent?). WHEREAS, the Company has determined that it is in its best interests to effect an initial public offering (?IPO?) of shares of its Class A co |
|
| November 8, 2021 |
Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION of DEFINITIVE HEALTHCARE CORP. (Pursuant to Section 242 and 245 of the General Corporation Law of the State of Delaware) Definitive Healthcare Corp., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), hereby certifies as follows: FIRST: The name of the Corporation is Definitive Healthcare C |
|
| November 8, 2021 |
Exhibit 10.16 September 30, 2021 BY EMAIL Kevin P. Shone 27 Grey Lane Lynnfield, MA 01940 [email protected] Dear Kevin: This letter agreement (the ?Agreement?) confirms our agreement relating to your separation from employment with Definitive Healthcare, LLC (the ?Company?). 1. Separation Date: Your employment with the Company shall end by your separation effective as of the close of busines |
|
| November 8, 2021 |
Exhibit 99.1 Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2021 Third quarter revenue grew 43% year-over-year to $43.1 million Framingham, MA (November 8, 2021) ? Definitive Healthcare Corp. (?Definitive Healthcare?) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended September 30, 2021. Thi |
|
| November 8, 2021 |
Exhibit 10.12 NOMINATING AGREEMENT This Nominating Agreement (this ?Agreement?), dated as of September 17, 2021, by and among Definitive Healthcare Corp., a Delaware corporation (the ?Company?), and SE VII DHC AIV, L.P. (?Spectrum?). WHEREAS, the Company has determined that it is in its best interests to effect an initial public offering (?IPO?) of shares of its Class A common stock, par value $0. |
|
| November 8, 2021 |
Exhibit 10.10 TAX RECEIVABLE AGREEMENT by and among DEFINITIVE HEALTHCARE CORP. AIDH TOPCO, LLC the several TRA HOLDERS (as defined herein) and OTHER TRA HOLDERS FROM TIME TO TIME PARTY HERETO Dated as of September 14, 2021 CONTENTS Page Article I. DEFINITIONS 2 Section 1.1 Definitions 2 Section 1.2 Rules of Construction 13 Article II. DETERMINATION OF REALIZED TAX BENEFIT 14 Section 2.1 Basis Adj |
|
| November 8, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 8, 2021 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Commission file number 1-40815 Delaware 86-3988281 (State of incorporation) (I.R.S. |
|
| November 8, 2021 |
Exhibit 10.9 REGISTRATION RIGHTS AGREEMENT by and among Definitive Healthcare Corp. and the other parties hereto September 14, 2021 TABLE OF CONTENTS Section 1. Certain Definitions 3 Section 2. Registration Rights 7 2.1. Demand Registrations 7 2.2. Piggyback Registrations 11 2.3. Holdback Agreements 13 2.4. Registration Procedures 13 2.5. Registration Expenses 18 2.6. No Required Sale 19 2.7. Inde |
|
| November 5, 2021 |
Table of Contents Confidential Treatment Requested by Definitive Healthcare Corp. Pursuant to 17 C.F.R. Section 200.83 As submitted confidentially with the Securities and Exchange Commission on November 5, 2021 This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confidential. Registration No. 333- UNI |
|
| October 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 7, 2021 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Commission file number 1-40815 Delaware 86-3988281 (State of incorporation) (I.R.S. |
|
| October 8, 2021 |
Robert Musslewhite Joins Definitive Healthcare as President Exhibit 99.1 Robert Musslewhite Joins Definitive Healthcare as President FRAMINGHAM, MA ? (October 7, 2021) ? Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that Robert Musslewhite has joined the company as President, a newly created role on the company?s Executive Leadership Team. ?Robert?s combination of deep healthcare expertise and |
|
| October 8, 2021 |
Exhibit 10.1 EMPLOYMENT AGREEMENT This Agreement (the ?Agreement?), dated as of October 7, 2021 (?Effective Date?), is made and entered into by and between Definitive Healthcare, LLC, a Massachusetts limited liability company (the ?Company?), and Robert Musslewhite (the ?Executive?). Introduction The Company desires to retain the services of the Executive pursuant to the terms and conditions set f |
|
| October 1, 2021 |
Definitive Healthcare Appoints Kathleen A. Winters to Board of Directors EX-99.1 2 d217445dex991.htm EX-99.1 EXHIBIT 99.1 Definitive Healthcare Appoints Kathleen A. Winters to Board of Directors FRAMINGHAM, MA (October 1, 2021) – Definitive Healthcare (NASDAQ: DH), an industry leader in healthcare commercial intelligence, today announced the appointment of Kathleen A. Winters to its Board of Directors and its Audit Committee. “Kathleen’s wealth of financial and operati |
|
| October 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 1, 2021 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Commission file number 1-40815 Delaware 86-3988281 (State of incorporation) (I.R.S. |
|
| September 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 17, 2021 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Commission file number 1-40815 Delaware 86-3988281 (State of incorporation) (I.R. |
|
| September 20, 2021 |
Exhibit 10.1 Published Deal CUSIP Number 24477GAA6 Published Revolver CUSIP Number: 24477GAB4 Published Term Loan A CUSIP Number: 24477GAC2 CREDIT AGREEMENT dated as of September 17, 2021 among DEFINITIVE HEALTHCARE HOLDINGS, LLC, as the Borrower, AIDH BUYER, LLC, as Holdings, THE FINANCIAL INSTITUTIONS PARTY HERETO as Lenders and Issuing Banks, and BANK OF AMERICA, N.A., as Administrative Agent, |
|
| September 20, 2021 |
Definitive Healthcare Announces Closing of Public Offering EX-99.1 3 d402153dex991.htm EX-99.1 EXHIBIT 99.1 Definitive Healthcare Announces Closing of Public Offering FRAMINGHAM, MA— (September 20, 2021) – Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the closing of its previously announced initial public offering of 17,888,888 shares of its Class A common stoc |
|
| September 16, 2021 |
15,555,555 Shares Definitive Healthcare Corp. Class A Common Stock 424B4 1 d127783d424b4.htm 424B4 Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-258990 PROSPECTUS 15,555,555 Shares Definitive Healthcare Corp. Class A Common Stock This is an initial public offering of Class A common stock by Definitive Healthcare Corp. In this prospectus, unless the context otherwise requires, “Definitive,” the “Company,” “we,” “us” and “our” refer (i) pr |
|
| September 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Definitive Healthcare Corp. (Exact Name of Registrant as Specified in Its Charter) Delaware 86-3988281 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification |
|
| September 15, 2021 |
As filed with the Securities and Exchange Commission on September 14, 2021 As filed with the Securities and Exchange Commission on September 14, 2021 Registration No. |
|
| September 13, 2021 |
As filed with the Securities and Exchange Commission on September 13, 2021 S-1/A Table of Contents As filed with the Securities and Exchange Commission on September 13, 2021 Registration No. |
|
| September 10, 2021 |
DEFINITIVE HEALTHCARE CORP. 550 Cochituate Rd Framingham, MA 01701 September 10, 2021 DEFINITIVE HEALTHCARE CORP. 550 Cochituate Rd Framingham, MA 01701 September 10, 2021 VIA EDGAR AND EMAIL Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street, NE Washington, D.C. 20549-3561 Attn: Matthew Crispino Re: Definitive Healthcare Corp. Registration Statement on Form S-1 (File No. 333-258990) Ladies and Gentlemen: We refer to the registratio |
|
| September 10, 2021 |
[Remainder of page intentionally left blank] VIA EDGAR September 10, 2021 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Definitive Healthcare Corp. (the ?Company?) Registration Statement on Form S-1 (File No. 333-258990) Ladies and Gentlemen: As representatives of the several underwriters of the Company?s proposed initial public offering of its Class A common stock, we hereby join the Company?s request that |
|
| September 7, 2021 |
Exhibit 10.19 STOCK AND UNIT PURCHASE AGREEMENT THIS STOCK AND UNIT PURCHASE AGREEMENT (this ?Agreement?) is entered into as of September 7, 2021 by and among Definitive Healthcare Corp., a Delaware corporation (the ?Company?) and certain persons listed on Schedule I hereto (each such securityholder a ?Seller? and collectively, the ?Sellers?). BACKGROUND A. The Board of Directors of the Company (t |
|
| September 7, 2021 |
Exhibit 10.18 DEFINTIIVE HEALTHCARE CORP. CONFIDENTIAL September , 2021 Definitive Healthcare Corp. 550 Cochituate Rd Framingham, MA 01701 Attention: David A. Samuels Expense Reimbursement Letter – Transactions Ladies and Gentlemen: We are writing to acknowledge the agreement of certain parties listed on the signature pages hereto (“you” or “your”) to work with Definitive Healthcare Corp. (the “Co |
|
| September 7, 2021 |
As filed with the Securities and Exchange Commission on September 7, 2021 Table of Contents As filed with the Securities and Exchange Commission on September 7, 2021 Registration No. |
|
| September 7, 2021 |
Form of Underwriting Agreement. EX-1.1 2 d127783dex11.htm EX-1.1 Exhibit 1.1 Definitive Healthcare Corp. [•] Shares of Common Stock Underwriting Agreement [•], 2021 Goldman Sachs & Co. LLC J.P. Morgan Securities LLC Morgan Stanley & Co. LLC Barclays Capital Inc. As Representatives of the several Underwriters listed in Schedule 1 hereto c/o Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 c/o J.P. Morgan Securitie |
|
| September 7, 2021 |
767 Fifth Avenue New York, NY 10153-0119 +1 212 310 8000 tel +1 212 310 8007 fax September 7, 2021 VIA EDGAR TRANSMISSION Matthew Crispino Staff Attorney Division of Corporation Finance Office of Technology Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D. |
|
| August 27, 2021 |
Form of Certificate of Class A Common Stock. Exhibit 4.1 DEFINITIVE HEALTHCARE CORP. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE SEE REVERSE SIDE FOR CERTAIN DEFINITIONS CUSIP 24477E 10 3 THIS CERTIFIES THAT is the owner of BY FULLY PAID AND NON-ASSESSABLE CLASS A COMMON SHARES, $0.001 PAR VALUE, OF (Brooklyn, AMERICAN COUNTERSIGNED DEFINITIVE HEALTHCARE CORP. New STOCKAND transferable on the books of the Corporation by the holder h |
|
| August 27, 2021 |
As filed with the Securities and Exchange Commission on August 27, 2021 S-1/A Table of Contents As filed with the Securities and Exchange Commission on August 27, 2021 Registration No. |
|
| August 20, 2021 |
Exhibit 10.9 EMPLOYMENT AGREEMENT This Agreement (the ?Agreement?), dated as of January 29th, 2021 (?Effective Date?), is made and entered into by and between Definitive Healthcare, LLC, a Massachusetts limited liability company (the ?Company?), and Richard Booth (the ?Executive?). Introduction The Company desires to retain the services of the Executive pursuant to the terms and conditions set for |
|
| August 20, 2021 |
Form of Nominating Agreement between the Company and Jason Krantz Exhibit 10.17 NOMINATING AGREEMENT This Nominating Agreement (this ?Agreement?), dated as of , 2021, by and among Definitive Healthcare Corp., a Delaware corporation (the ?Company?), and Jason Krantz. WHEREAS, the Company has determined that it is in its best interests to effect an initial public offering (?IPO?) of shares of its Class A common stock, par value $0.001 per share (together with the |
|
| August 20, 2021 |
Exhibit 10.2 THE DEFINITIVE HEALTHCARE CORP. 2021 EQUITY INCENTIVE PLAN 1. Purpose. The purpose of the Definitive Healthcare Corp. 2021 Equity Incentive Plan is to further align the interests of eligible participants with those of the Company?s stockholders by providing incentive compensation opportunities tied to the performance of the Company and its Common Stock. The Plan is intended to advance |
|
| August 20, 2021 |
Exhibit 10.7 THE DEFINITIVE HEALTHCARE CORP. 2021 EMPLOYEE STOCK PURCHASE PLAN 1. General; Purpose. (a) The Plan provides a means by which Eligible Employees and/or Eligible Service Providers of either the Company or a Designated Company may be given an opportunity to purchase Common Stock. The Plan permits the Company to grant a series of Purchase Rights to Eligible Employees and/or Eligible Serv |
|
| August 20, 2021 |
Exhibit 10.8 EMPLOYMENT AGREEMENT This Agreement (the ?Agreement?), dated as of February 18, 2015, is made and entered into by and between Definitive Healthcare, LLC, a Massachusetts limited liability company (the ?Company?), and Jason Krantz (the ?Executive?). Introduction Reference is made to the Securities Purchase Agreement, dated on or about the date hereof, by and among the Definitive Health |
|
| August 20, 2021 |
Exhibit 10.11 CREDIT AGREEMENT Dated as of July 16, 2019 among AIDH FINANCE SUB, LLC, and following the consummation of the Merger, DEFINITIVE HEALTHCARE HOLDINGS, LLC as the Borrower, AIDH BUYER, LLC, as Holdings, THE FINANCIAL INSTITUTIONS PARTY HERETO as Lenders and Issuing Banks, and OWL ROCK CAPITAL CORPORATION, as Administrative Agent and an Issuing Bank OWL ROCK CAPITAL ADVISORS LLC, as Lea |
|
| August 20, 2021 |
EX-10.12 18 d127783dex1012.htm EX-10.12 Exhibit 10.12 REORGANIZATION AGREEMENT This REORGANIZATION AGREEMENT (this “Agreement”), dated as of , 2021, is entered into by and among (a) AIDH TopCo, LLC, a Delaware limited liability company (the “Company”); (b) Definitive Healthcare Corp., a Delaware corporation (“Pubco”) and (c) AIDH Holdings, Inc., a Delaware corporation (“Advent Blocker”); SE VII DH |
|
| August 20, 2021 |
Exhibit 10.5 Definitive Healthcare Corp. 2021 Equity Incentive Plan Restricted Stock Unit Award Agreement This Restricted Stock Unit Award Agreement (this ?Agreement?) is made by and between Definitive Healthcare Corp., a Delaware corporation (the ?Company?), and (the ?Participant?), effective as of , 2021 (the ?Date of Grant?). RECITALS WHEREAS, the Company has adopted the Definitive Healthcare C |
|
| August 20, 2021 |
Exhibit 10.10 EMPLOYMENT AGREEMENT This Agreement (the ?Agreement?), dated as of February 1, 2021 (?Effective Date?), is made and entered into by and between Definitive Healthcare, LLC, a Massachusetts limited liability company (the ?Company?), and David Samuels (the ?Executive?). Introduction The Company desires to retain the services of the Executive pursuant to the terms and conditions set fort |
|
| August 20, 2021 |
EX-21.1 24 d127783dex211.htm EX-21.1 Exhibit 21.1 Subsidiaries of the Registrant Entity Name Jurisdiction of Incorporation AIDH TopCo, LLC Delaware AIDH Buyer, LLC Delaware Definitive Healthcare Holdings, LLC Delaware Definitive Healthcare, LLC Massachusetts Healthcare Sales Enablement, Inc. Delaware Monocl Holding Company Delaware Monocl Company Delaware Monocl AB Sweden |
|
| August 20, 2021 |
S-1 Table of Contents As filed with the Securities and Exchange Commission on August 20, 2021 Registration No. |
|
| August 20, 2021 |
EX-3.1 2 d127783dex31.htm EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION of DEFINITIVE HEALTHCARE CORP. (Pursuant to Section 242 and 245 of the General Corporation Law of the State of Delaware) Definitive Healthcare Corp., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), hereby certifies as follows: FIRST: The name of the Corpo |
|
| August 20, 2021 |
Exhibit 10.1 AIDH TOPCO, LLC 2019 EQUITY INCENTIVE PLAN ARTICLE I ESTABLISHMENT, DEFINITIONS AND PURPOSE 1.1 Establishment. AIDH Topco, LLC, a Delaware limited liability company (the ?Company?), hereby establishes the AIDH Topco, LLC 2019 Equity Incentive Plan (the ?Plan?). The Plan shall become effective as of September 13, 2019. 1.2 Definitions. Capitalized terms used but not otherwise defined h |
|
| August 20, 2021 |
Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF DEFINITIVE HEALTHCARE CORP. (a Delaware corporation) Effective , 2021 ARTICLE I STOCKHOLDERS Section 1.01. Annual Meetings. The annual meeting of the stockholders of Definitive Healthcare Corp. (the ?Corporation?) for the election of directors and for the transaction of such other business as properly may come before such meeting shall be held at such pla |
|
| August 20, 2021 |
767 Fifth Avenue New York, NY 10153-0119 +1 212 310 8000 tel +1 212 310 8007 fax August 20, 2021 VIA EDGAR TRANSMISSION Matthew Crispino Staff Attorney Division of Corporation Finance Office of Technology Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D. |
|
| August 20, 2021 |
Exhibit 10.6 FORM OF DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the ?Agreement?) is made and entered into as of , 2021, between Definitive Healthcare Corp., a Delaware corporation (the ?Company?), and (?Indemnitee?). Capitalized terms not defined elsewhere in this Agreement are used as defined in Section 13. WHEREAS, the Board of Directors of the Company (the ?B |
|
| August 20, 2021 |
Form of Nominating Agreement between the Company and Advent. Exhibit 10.15 NOMINATING AGREEMENT This Nominating Agreement (this ?Agreement?), dated as of , 2021, by and among Definitive Healthcare Corp., a Delaware corporation (the ?Company?), and (?Advent?). WHEREAS, the Company has determined that it is in its best interests to effect an initial public offering (?IPO?) of shares of its Class A common stock, par value $0.001 per share (together with the Co |
|
| August 20, 2021 |
Form of Tax Receivable Agreement between Definitive Healthcare Corp. and the TRA Parties. Exhibit 10.14 TAX RECEIVABLE AGREEMENT by and among DEFINITIVE HEALTHCARE CORP. AIDH TOPCO, LLC the several TRA HOLDERS (as defined herein) and OTHER TRA HOLDERS FROM TIME TO TIME PARTY HERETO Dated as of [Month] [ ], 2021 CONTENTS Page Article I. DEFINITIONS 2 Section 1.1 Definitions 2 Section 1.2 Rules of Construction. Unless otherwise specified herein: 13 Article II. DETERMINATION OF REALIZED T |
|
| August 20, 2021 |
Exhibit 3.3 SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT of AIDH TOPCO, LLC Dated as of , 2021 ARTICLE 1 DEFINITIONS AND USAGE 1 Section 1.01. Definitions 1 Section 1.02. Other Definitional and Interpretative Provisions 11 ARTICLE 2 THE COMPANY 12 Section 2.01. Formation 12 Section 2.02. Name 12 Section 2.03. Term 12 Section 2.04. Registered Agent and Registered Office 12 Sectio |
|
| August 20, 2021 |
Bylaws of Definitive Healthcare Corp., as currently in effect. Exhibit 3.5 BYLAWS OF DEFINITIVE HEALTHCARE CORP. A DELAWARE CORPORATION PREAMBLE These Bylaws are subject to, and governed by, the General Corporation Law of the State of Delaware (the ?Delaware General Corporation Law?) and the Certificate of Incorporation (the ?Certificate?) of Definitive Healthcare Corp., a Delaware corporation (the ?Corporation?). In the event of a direct conflict between the |
|
| August 20, 2021 |
Exhibit 10.4 Definitive Healthcare Corp. 2021 Equity Incentive Plan Restricted Stock Unit Award Agreement This Restricted Stock Unit Award Agreement (this ?Agreement?) is made by and between Definitive Healthcare Corp., a Delaware corporation (the ?Company?), and (the ?Participant?), effective as of , 2021 (the ?Date of Grant?). RECITALS WHEREAS, the Company has adopted the Definitive Healthcare C |
|
| August 20, 2021 |
Exhibit 10.13 REGISTRATION RIGHTS AGREEMENT by and among Definitive Healthcare Corp. and the other parties hereto , 2021 TABLE OF CONTENTS Section 1. Certain Definitions 1 Section 2. Registration Rights 5 2.1. Demand Registrations 5 2.2. Piggyback Registrations 9 2.3. Holdback Agreements 11 2.4. Registration Procedures 11 2.5. Registration Expenses 16 2.6. No Required Sale 16 2.7. Indemnification |
|
| August 20, 2021 |
Exhibit 10.3 AIDH TOPCO, LLC 2019 EQUITY INCENTIVE PLAN TOPCO CLASS B UNIT GRANT AGREEMENT THIS CLASS B UNIT GRANT AGREEMENT (the ?Agreement?) is made as of September 18, 2019 (the ?Grant Date?) among AIDH Topco, LLC, a Delaware limited liability company (the ?Company?), AIDH Management Holdings, LLC a Delaware limited liability company (the ?Participant?), and (the ?Service Provider?). R E C I T |
|
| August 20, 2021 |
Certificate of Incorporation of Definitive Healthcare Corp., as currently in effect. Exhibit 3.4 CERTIFICATE OF INCORPORATION OF DEFINITIVE HEALTHCARE CORP. THE UNDERSIGNED, being a natural person for the purpose of organizing a corporation under the General Corporation Law of the State of Delaware, hereby certifies that: FIRST: The name of the Corporation is Definitive Healthcare Corp. (the ?Corporation?). SECOND: The address of its registered office in the State of Delaware is 1 |
|
| August 20, 2021 |
Form of Nominating Agreement between the Company and SE VII DHC AIV, L.P. Exhibit 10.16 NOMINATING AGREEMENT This Nominating Agreement (this ?Agreement?), dated as of , 2021, by and among Definitive Healthcare Corp., a Delaware corporation (the ?Company?), and SE VII DHC AIV, L.P. (?Spectrum?). WHEREAS, the Company has determined that it is in its best interests to effect an initial public offering (?IPO?) of shares of its Class A common stock, par value $0.001 per shar |
|
| August 5, 2021 |
CERTIFICATE OF INCORPORATION DEFINITIVE HEALTHCARE CORP. EX-3.3 2 filename2.htm Exhibit 3.3 CERTIFICATE OF INCORPORATION OF DEFINITIVE HEALTHCARE CORP. THE UNDERSIGNED, being a natural person for the purpose of organizing a corporation under the General Corporation Law of the State of Delaware, hereby certifies that: FIRST: The name of the Corporation is Definitive Healthcare Corp. (the “Corporation”). SECOND: The address of its registered office in the |
|
| August 5, 2021 |
Subsidiaries of the Registrant Exhibit 21.1 Subsidiaries of the Registrant Entity Name Jurisdiction of Incorporation AIDH TopCo, LLC Delaware AIDH Buyer, LLC Delaware Definitive Healthcare Holdings, LLC Delaware Definitive Healthcare, LLC Massachusetts Healthcare Sales Enablement, Inc. Delaware Monocl Holding Company Delaware Monocl Company Delaware Monocl AB Sweden |
|
| August 5, 2021 |
BYLAWS OF DEFINITIVE HEALTHCARE CORP. A DELAWARE CORPORATION Exhibit 3.4 BYLAWS OF DEFINITIVE HEALTHCARE CORP. A DELAWARE CORPORATION PREAMBLE These Bylaws are subject to, and governed by, the General Corporation Law of the State of Delaware (the ?Delaware General Corporation Law?) and the Certificate of Incorporation (the ?Certificate?) of Definitive Healthcare Corp., a Delaware corporation (the ?Corporation?). In the event of a direct conflict between the |
|
| August 5, 2021 |
767 Fifth Avenue New York, NY 10153-0119 +1 212 310 8000 tel +1 212 310 8007 fax August 5, 2021 VIA EDGAR TRANSMISSION Matthew Crispino Staff Attorney Division of Corporation Finance Office of Technology Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D. |
|
| August 5, 2021 |
EX-10.9 4 filename4.htm Exhibit 10.9 CREDIT AGREEMENT Dated as of July 16, 2019 among AIDH FINANCE SUB, LLC, and following the consummation of the Merger, DEFINITIVE HEALTHCARE HOLDINGS, LLC as the Borrower, AIDH BUYER, LLC, as Holdings, THE FINANCIAL INSTITUTIONS PARTY HERETO as Lenders and Issuing Banks, and OWL ROCK CAPITAL CORPORATION, as Administrative Agent and an Issuing Bank OWL ROCK CAPIT |
|
| August 5, 2021 |
Table of Contents Amendment No. 2 to confidential submission As submitted confidentially with the Securities and Exchange Commission on August 5, 2021 This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confidential. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| June 30, 2021 |
767 Fifth Avenue New York, NY 10153-0119 +1 212 310 8000 tel +1 212 310 8007 fax June 30, 2021 VIA EDGAR TRANSMISSION Matthew Crispino Staff Attorney Division of Corporation Finance Office of Technology Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D. |
|
| June 30, 2021 |
EX-10.6 2 filename2.htm Exhibit 10.6 EMPLOYMENT AGREEMENT This Agreement (the “Agreement”), dated as of February 18, 2015, is made and entered into by and between Definitive Healthcare, LLC, a Massachusetts limited liability company (the “Company”), and Jason Krantz (the “Executive”). Introduction Reference is made to the Securities Purchase Agreement, dated on or about the date hereof, by and amo |
|
| June 30, 2021 |
EX-10.7 3 filename3.htm Exhibit 10.7 EMPLOYMENT AGREEMENT This Agreement (the “Agreement”), dated as of January 29th, 2021 (“Effective Date”), is made and entered into by and between Definitive Healthcare, LLC, a Massachusetts limited liability company (the “Company”), and Richard Booth (the “Executive”). Introduction The Company desires to retain the services of the Executive pursuant to the term |
|
| June 30, 2021 |
DRS/A 1 filename1.htm Table of Contents Amendment No. 1 to confidential submission As submitted confidentially with the Securities and Exchange Commission on June 30, 2021 This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confidential. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMM |
|
| June 30, 2021 |
EX-10.8 4 filename4.htm Exhibit 10.8 EMPLOYMENT AGREEMENT This Agreement (the “Agreement”), dated as of February 1, 2021 (“Effective Date”), is made and entered into by and between Definitive Healthcare, LLC, a Massachusetts limited liability company (the “Company”), and David Samuels (the “Executive”). Introduction The Company desires to retain the services of the Executive pursuant to the terms |
|
| May 28, 2021 |
767 Fifth Avenue New York, NY 10153-0119 +1 212 310 8000 tel +1 212 310 8007 fax May 28, 2021 Alexander D. |
|
| May 28, 2021 |
Table of Contents As submitted confidentially with the Securities and Exchange Commission on May 28, 2021 This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confidential. |
